Some studies have reported the clinical and pathologic characteristics of NSCLC patients harboring BRAF mutations, our study mainly explored the treatment pattern and clinical outcomes of various BRAF genomic subtype among these patients. The gene discussed is BRAF; the disease is non-small cell lung carcinoma.